共 50 条
- [41] Regorafenib for previously treated metastatic colorectal cancer (mCRC): results from 683 Italian patients treated in the open-label phase IIIB CONSIGN studyANNALS OF ONCOLOGY, 2015, 26 : 37 - 37Ciardiello, F.Salvatore, L.Cascinu, S.Sobrero, A.Banzi, M.Barone, C.Spallanzani, A.Latiano, T. L.Amatu, A.Zagonel, V.Biglietto, M.Di Costanzo, F.Di Bartolomeo, M.Santoro, A.Russo, A.Moscovici, M.Van Cutsem, E.Zaniboni, A.
- [42] Prolonged clinical benefit with metronomic capecitabine plus oral vinorelbine as treatment of metastatic breast cancer: Results from a phase II study.JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Orlando, LauraFedele, PalmaSchiavone, PaolaNacci, AngeloCalvani, NicolaMazzoni, EnricaQuaranta, AnnamariaCinefra, MargheritaCinieri, Saverio
- [43] Efficacy and safety of nivolumab in patients with non-clear cell renal cell carcinoma (RCC): Results from the phase IIIb/IV CheckMate 374 study.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)Vogelzang, Nicholas J.McFarlane, Joshua JemisonKochenderfer, Mark D.Molina, Ana M.Arrowsmith, EdwardBauer, Todd MichaelHauke, Ralph J.Jain, RohitSomer, Bradley G.Lam, Elaine TatDoshi, Gurjyot K.Gunuganti, VijayZhang, JoshuaZhao, HuanyuJohansen, JenniferTykodi, Scott S.
- [44] Intra- and post-operative catumaxomab in patients with epithelial ovarian cancer: Two-year efficacy results from a multicenter, single-arm, phase II study.JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Sehouli, J.Reinthaller, A.Marth, C.Reimer, D.Reimer, T.Stummvoll, W.Angleitner-Boubenizek, L.Lehnert, B.Marquardt, M.Essing, M. M.Chekerov, R.
- [45] Sacituzumab govitecan (SG) in patients (pts) with previously treated metastatic endometrial cancer (mEC): results from a phase I/II study.JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)Santin, AlessandroKomiya, TakefumiGoldenberg, David M.Sharkey, Robert M.Hong, QuanWegener, William A.Goswami, TrishnaBardia, Aditya
- [46] Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort studyFRONTIERS IN IMMUNOLOGY, 2022, 13Torres-Ruiz, JiramLomelin-Gascon, JulietaSofia Vargas-Castro, AnaLira-Luna, JaquelinPerez-Fragoso, AlfredoTapia-Conyer, RobertoNunez-Aguirre, MiroslavaAlcala-Carmona, BeatrizAbsalon-Aguilar, AbdielLuis Maravillas-Montero, JoseRaquel Mejia-Dominguez, NancyNunez-Alvarez, CarlosRull-Gabayet, MarinaLlorente, LuisRomero-Ramirez, SandraAndres Sosa-Hernandez, VictorCervantes-Diaz, RodrigoJuarez-Vega, GuillermoEduardo Meza-Sanchez, DavidAlberto Martinez-Juarez, LuisMorales-Juarez, LindaNaomi Lopez-Lopez, LizethAdrian Negrete-Trujillo, JoseAbelardo Falcon-Lezama, JorgeRicardo Valdez-Vazquez, RafaelGallardo-Rincon, HectorGomez-Martin, Diana
- [47] Phase II clinical study of ST1571 in Japanese (Jpn) patients (pts) with malignant gastrointestinal stromal tumors (GIST): Results of the B1201 study.JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 332S - 332SDoi, TNishida, THirota, SSugiyama, TYamao, KKoseki, MOkamura, TShirao, KOhtsu, A
- [48] Virological and Clinical Response in Patients with HCV-Related Mixed Cryoglobulinemia Treated with Interferon-Free Regimens: Preliminary Results of a Prospective Pilot Study.HEPATOLOGY, 2015, 62 : 798A - 798AGragnani, LauraPiluso, AlessiaUrraro, TeresaFabbrizzi, AlessioFognani, ElisaPetraccia, LuisaMonti, MonicaZignego, Anna Linda
- [49] Durability of Initial Platelet Count Response in Patients Treated with Avatrombopag for Immune Thrombocytopenia (ITP): Post-Hoc Results from a Phase 3 Clinical StudyBLOOD, 2020, 136Jain, ShiviWojdyla, MatthewVredenburg, MichaelJamieson, BrianGernsheimer, Terry B.
- [50] Sacituzumab govitecan (IMMU-132) in patients with previously treated metastatic urothelial cancer (mUC): Results from a phase I/II study.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)Tagawa, Scott T.Faltas, Bishoy MorrisLam, Elaine TatSaylor, Philip JamesBardia, AdityaHajdenberg, JulioMorgans, Alicia K.Lim, Emerson A.Kalinsky, KevinSimpson, Pamela S.Galsky, Matt D.Goswam, TrishnaWegener, William A.Petrylak, Daniel Peter